Amundi Index Euro AGG Corporate SRI Fund is a bonds ETF from Amundi tracking the Index Solutions - Amundi Index Euro AGG Corporate SRI Fund index through physical replication. Domiciled in Luxembourg and launched in 2017, the fund manages about 671 M € and charges a TER of 0.14% — 14 € per year on a €10,000 investment. Income is paid out to investors periodically (distributing).
Amundi Index Euro AGG Corporate SRI Fund competes with 365 other products in the same class and region (Bonds, Global): it ranks 111th by fund size and 148th by ongoing cost, with a TER of 0.14% against a group median of 0.15%. It has been listed since 2017, 9 years of track record.
On a €10,000 investment the TER costs 14 € a year, against 15 € for the median product in the category.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 1.9% of the portfolio.
Income is distributed periodically: it produces cash flow, but reinvesting it is up to you if the goal is capital growth. The fund is denominated in EUR. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
The fund is domiciled in Luxembourg, which determines the tax treatment of income received by the fund and the supervisory authority.
| JPMorgan Chase & Co. 1.5% | 0.3% |
| BP Capital Markets plc | 0.2% |
| Autoroutes Du Sud De La France 1.25% | 0.2% |
| Credit Suisse Group AG 1.25% | 0.2% |
| Banque Federative du Credit Mutuel 0.5% | 0.2% |
| Commerzbank Aktiengesellschaft 0.5% | 0.2% |
| Orange S.A. 8.12% | 0.2% |
| Siemens Financieringsmaatschappij N.V. 1.38% | 0.2% |
| Bank of America Corporation | 0.2% |
| XETRA | DECR | EUR |
| Francoforte | DECR | EUR |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.